ADUS Addus HomeCare Corporation
Stock · NasdaqGS · United States · Healthcare · US0067391062
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Addus HomeCare Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
124.31 USD
-1.97%
52-week range
87.95 – 131.59
Dividend yield—
Market cap2.3B
NowoTrade score
80 Grade A
Price history
Daily prices in USD.
Updated 07 Nov 2026 10:07. Information, not advice.
Results
Next results
22 Feb 2027
in 107 days · 16:00 · estimate 1.91
Last results
1.83 vs 1.79 estimated
03 Nov 2026 · Beat +2.1%
Beat the estimate
12 of 12
0 missed · 0 in line · 12 beats in a row
Average surprise
+4.7%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 22 Feb 2027 16:00 | 1.91 | — | — | Upcoming |
| 03 Nov 2026 16:00 | 1.79 | 1.83 | +2.1% | Beat |
| 03 Aug 2026 16:00 | 1.70 | 1.73 | +1.9% | Beat |
| 04 May 2026 16:00 | 1.54 | 1.62 | +4.9% | Beat |
| 23 Feb 2026 16:00 | 1.72 | 1.77 | +2.6% | Beat |
| 03 Nov 2025 16:00 | 1.53 | 1.56 | +1.7% | Beat |
| 04 Aug 2025 16:00 | 1.46 | 1.49 | +1.9% | Beat |
| 05 May 2025 16:00 | 1.33 | 1.42 | +6.5% | Beat |
| 24 Feb 2025 16:00 | 1.36 | 1.38 | +1.6% | Beat |
| 04 Nov 2024 16:00 | 1.28 | 1.30 | +1.3% | Beat |
| 05 Aug 2024 16:00 | 1.22 | 1.35 | +10.9% | Beat |
| 06 May 2024 16:00 | 1.11 | 1.21 | +8.7% | Beat |
| 26 Feb 2024 16:00 | 1.17 | 1.32 | +12.7% | Beat |
| 30 Oct 2023 16:00 | 1.08 | 1.15 | +6.3% | Beat |
| 31 Jul 2023 16:00 | 1.01 | 1.07 | +5.9% | Beat |
| 01 May 2023 16:00 | 0.91 | 0.97 | +6.6% | Beat |
| 27 Feb 2023 16:00 | 0.97 | 1.11 | +15.0% | Beat |
| 31 Oct 2022 16:00 | 0.94 | 0.94 | +0.5% | In line |
| 01 Aug 2022 16:00 | 0.92 | 0.91 | -1.5% | Miss |
| 02 May 2022 16:00 | 0.76 | 0.77 | +1.3% | Beat |
| 24 Feb 2022 16:00 | 0.92 | 0.97 | +5.4% | Beat |
| 01 Nov 2021 16:00 | 0.91 | 0.91 | +0.2% | In line |
| 02 Aug 2021 16:00 | 0.89 | 0.90 | +1.6% | Beat |
| 03 May 2021 16:00 | 0.75 | 0.74 | -1.5% | Miss |
| 25 Feb 2021 16:00 | 0.74 | 0.82 | +10.2% | Beat |
| 02 Nov 2020 16:00 | 0.65 | 0.76 | +16.3% | Beat |
| 10 Aug 2020 17:00 | 0.48 | 0.73 | +51.4% | Beat |
| 04 May 2020 17:00 | 0.59 | 0.77 | +31.5% | Beat |
| 17 Mar 2020 16:00 | 0.65 | 0.73 | +12.3% | Beat |
| 04 Nov 2019 16:00 | 0.57 | 0.62 | +9.4% | Beat |
| 05 Aug 2019 16:00 | 0.53 | 0.56 | +6.2% | Beat |
| 06 May 2019 16:00 | 0.46 | 0.52 | +13.0% | Beat |
| 04 Mar 2019 16:00 | 0.49 | 0.55 | +11.6% | Beat |
| 05 Nov 2018 16:00 | 0.44 | 0.48 | +8.8% | Beat |
| 06 Aug 2018 16:00 | 0.49 | 0.50 | +2.6% | Beat |
| 07 May 2018 16:00 | 0.40 | 0.42 | +4.1% | Beat |
| 05 Mar 2018 16:00 | 0.44 | 0.46 | +4.6% | Beat |
| 06 Nov 2017 16:00 | 0.41 | 0.42 | +2.4% | Beat |
| 07 Aug 2017 16:00 | 0.37 | 0.38 | +2.0% | Beat |
| 08 May 2017 16:00 | 0.33 | 0.34 | +3.8% | Beat |
| 06 Mar 2017 16:00 | 0.36 | 0.43 | +20.3% | Beat |
| 07 Nov 2016 16:00 | 0.31 | 0.39 | +24.8% | Beat |
| 01 Aug 2016 16:00 | 0.31 | 0.31 | +1.6% | Beat |
| 02 May 2016 16:00 | 0.27 | 0.28 | +4.5% | Beat |
| 07 Mar 2016 16:00 | 0.29 | 0.29 | +1.4% | Beat |
| 02 Nov 2015 16:00 | 0.25 | 0.25 | 0.0% | In line |
| 03 Aug 2015 16:00 | 0.31 | 0.30 | -3.2% | Miss |
| 30 Apr 2015 16:00 | 0.24 | 0.24 | 0.0% | In line |
| 05 Mar 2015 16:00 | 0.30 | 0.36 | +19.2% | Beat |
| 30 Oct 2014 16:00 | 0.29 | 0.29 | 0.0% | In line |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 1.4B | +23.2% | 95.9M | 6.7% | 5.18 | +27.7% | 103.8M |
| 2024 | 1.2B | +9.1% | 73.6M | 6.4% | 4.06 | +5.9% | 110.4M |
| 2023 | 1.1B | +11.3% | 62.5M | 5.9% | 3.83 | +34.9% | 102.8M |
| 2022 | 951.1M | — | 46M | 4.8% | 2.84 | — | 96.8M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Oct 2024 | 132.48 | 134.32 | 123.45 | 124.42 | -6.47% | 2,449,700 | |
| Sep 2024 | 132.16 | 136.12 | 123.16 | 133.03 | +0.02% | 2,418,600 | |
| Aug 2024 | 121.78 | 134.78 | 114.97 | 133.01 | +9.60% | 2,971,800 | |
| Jul 2024 | 116.69 | 125.24 | 115.63 | 121.36 | +4.52% | 3,412,000 | |
| Jun 2024 | 114.87 | 120.53 | 110.48 | 116.11 | +1.13% | 3,726,100 | |
| May 2024 | 96.04 | 115.10 | 96.04 | 114.81 | +19.41% | 2,485,800 | |
| Apr 2024 | 103.93 | 104.39 | 87.88 | 96.15 | -6.96% | 3,179,900 | |
| Mar 2024 | 92.61 | 104.61 | 92.02 | 103.34 | +11.99% | 2,394,100 | |
| Feb 2024 | 86.61 | 97.22 | 85.94 | 92.28 | +6.56% | 2,746,200 | |
| Jan 2024 | 92.64 | 95.20 | 86.30 | 86.60 | -6.73% | 1,804,200 | |
| Dec 2023 | 87.01 | 97.65 | 85.43 | 92.85 | +6.48% | 1,894,200 | |
| Nov 2023 | 78.90 | 90.62 | 78.35 | 87.20 | +10.52% | 1,304,000 | |
| Oct 2023 | 84.79 | 85.82 | 78.68 | 78.90 | -7.38% | 1,627,600 | |
| Sep 2023 | 87.86 | 88.77 | 81.97 | 85.19 | -2.86% | 1,581,100 | |
| Aug 2023 | 94.55 | 97.06 | 87.56 | 87.70 | -4.23% | 2,073,300 | |
| Jul 2023 | 92.70 | 93.80 | 86.10 | 91.57 | -1.22% | 2,265,400 | |
| Jun 2023 | 89.77 | 95.63 | 89.17 | 92.70 | +2.83% | 3,026,900 | |
| May 2023 | 83.60 | 90.69 | 77.30 | 90.15 | +10.29% | 4,233,000 | |
| Apr 2023 | 107.41 | 114.97 | 77.47 | 81.74 | -23.44% | 3,119,100 | |
| Mar 2023 | 107.25 | 109.99 | 96.76 | 106.76 | -1.73% | 2,490,400 | |
| Feb 2023 | 106.70 | 114.99 | 102.85 | 108.64 | +1.04% | 1,812,400 | |
| Jan 2023 | 99.70 | 112.61 | 97.25 | 107.52 | +8.07% | 1,381,900 | |
| Dec 2022 | 111.17 | 112.89 | 98.07 | 99.49 | -9.78% | 1,960,600 | |
| Nov 2022 | 107.11 | 111.50 | 102.32 | 110.28 | +7.67% | 1,982,200 | |
| Oct 2022 | 95.68 | 112.11 | 92.04 | 102.42 | +7.54% | 2,726,200 |
Page 2 of 3
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- What Makes Addus HomeCare (ADUS) a Strong Momentum Stock: Buy Now? (opens in a new tab) Zacks · 06 Nov 2026 16:00
- Should Value Investors Buy Addus HomeCare (ADUS) Stock? (opens in a new tab) Zacks · 06 Nov 2026 13:40
- Addus HomeCare Corporation (ADUS) Hit a 52 Week High, Can the Run Continue? (opens in a new tab) Zacks · 06 Nov 2026 13:15
- Does Earnings Beat Change The Bull Case For Addus HomeCare Stock (ADUS)? (opens in a new tab) Simply Wall St. · 06 Nov 2026 10:15
- UBS Maintains Buy on Addus HomeCare, Raises Price Target to $160 (opens in a new tab) Benzinga · 05 Nov 2026 20:10
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch (opens in a new tab) MarketBeat · 05 Nov 2026 18:55
- TD Cowen Maintains Buy on Addus HomeCare, Raises Price Target to $145 (opens in a new tab) Benzinga · 05 Nov 2026 16:29
- Truist Securities Maintains Buy on Addus HomeCare, Raises Price Target to $148 (opens in a new tab) Benzinga · 05 Nov 2026 11:29
- Addus HomeCare Corp (ADUS) (Q3 2026) Earnings Call Highlights: Revenue Climbs 7% as AccentCare ... (opens in a new tab) GuruFocus.com · 05 Nov 2026 01:08
- Addus HomeCare (ADUS) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 04 Nov 2026 18:00
- Addus HomeCare Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 04 Nov 2026 16:14
- Addus HomeCare Corporation (ADUS) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 04 Nov 2026 15:04
- Addus HomeCare Corporation Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 04 Nov 2026 13:30
- Barclays Maintains Underweight on Addus HomeCare, Raises Price Target to $101 (opens in a new tab) Benzinga · 04 Nov 2026 12:51
- Addus HomeCare Q3 2026 Earnings Call Transcript (opens in a new tab) Benzinga · 04 Nov 2026 11:25
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 126.81 USD
- Market cap
- 2.3B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 24.5 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 14.1 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 20.0 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 13.5 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 6.2 / 10 |
|
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A).
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 20.68× | Fair | 31.09× |
| P/E (forward) | 16.3× | Fair | 14.98× |
| Price / book | 1.92× | Fair | 3.94× |
| Price / sales | 1.54× | Good | 3.37× |
| EV / EBITDA | 12.95× | Fair | 12.96× |
| Free cash flow yield | 4.8% | Fair | 2.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 32.3% | Fair | 59.2% |
| Operating margin | 10.3% | Fair | 7.4% |
| Net margin | 7.4% | Fair | 3.4% |
| Return on equity | 10% | Fair | 5.7% |
| Return on assets | 6.8% | Fair | 3.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 14.4% | Good | 10.8% |
| EPS growth / year | 22.2% | Good | 10.2% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.06× | Good | 0.46× |
| Net debt / EBITDA | -0.18× | Good | 1.5× |
| Interest cover | 10.18× | Good | 3.26× |
| Current ratio | 1.64× | Good | 2.35× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow ADUS and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.